menu Search
American Taiwan Biopharm
American Taiwan Biopharm

SHILPA MEDICARE LIMITED

Featured products of Shilpa Medicare
Renavel
Renavel FC tab 1 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Renavel FC tab 5 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Distributed by American Taiwan Biopharm
Renavel
Renavel FC tab 1 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Renavel FC tab 5 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Marketed by American Taiwan Biopharm
Renavel
Renavel FC tab 1 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Renavel FC tab 5 mg
axitinib
Packing/Price
1 × 14's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EK01 - axitinib : Belongs to the class of vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.
Other products of Shilpa Medicare